See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100397_2019_Ayala_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001100397, Ayala Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 50,465,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,838,000 |
| 2 | PropertyPlantAndEquipmentNet | 6,684,000 |
| 3 | remainder_Assets | 280,000 |
| 4 | LiabilitiesCurrent | 22,872,000 |
| 5 | LiabilitiesNoncurrent | 1,155,000 |
| 6 | remainder_Liabilities | 14,189,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 25,814,147 |
| 9 | ResearchAndDevelopmentExpense | 58,703,377 |
| 10 | remainder_Expenses | -1,120,907 |
| 11 | remainder_Revenues | 7,219,069 |
| 12 | remainder_NetIncome | 3,193,292 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 62,267,000 |
| 1 | Liabilities | 38,216,000 |
| 2 | Expenses | 83,396,617 |
| 3 | Revenues | 7,219,069 |
| 4 | StockholdersEquity | 24,051,000 |
| 5 | NetIncome | -72,984,256 |
| 6 | ComprehensiveNetIncome | -72,984,256 |
| 7 | BaseVar | 97,145,989 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.409 |
| 9 | EconomicCapitalRatio | 1.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
